Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Epidemiology of Inhibitors in Persons with Severe Hemophilia a in the United States: Analyses of a National Database

Christopher M Sande, BSc, Amanda B Payne, MPH, PhD, Christine L Kempton, MD MSc, Marilyn J Manco-Johnson, MD, Anjali Sharathkumar, MBBS, MDMS

Blood (2018) 132 (Supplement 1): 2470.

https://doi.org/10.1182/blood-2018-99-109978

Published: 2018

Journal Articles

Early Prophylaxis Provides Continued Joint Protection in Severe Hemophilia A: Results of the Joint Outcome Continuation Study

Beth Boulden Warren, MD MS, Dianne Thornhill, PhD, Jill Stein, MD, Michael Fadell, MD, Sharon Funk, DPT, Heidi D. Lane, DPT, Carolyn M. Bennett, MD MSc, Amy Shapiro, Michael Recht, MD PhD, Marilyn J Manco-Johnson, MD

Blood (2018) 132 (Supplement 1): 382.

https://doi.org/10.1182/blood-2018-99-117413

Published: 2018

Journal Articles

Outcomes of Severe Hemophilia a Patients on Continuous Prophylaxis Relative to Inhibitor Status in the Community Counts Registry

Marilyn J. Manco-Johnson, MD, Vanessa R. Byams, MPH, Roshni Kulkarni, MD, Brandi Dupervil, MPH, Becky Dudley, LCSW, Tyler W. Buckner, MD MSc, Diane Aschman, Pharm D, Meredith Oakley, DVM, MPH, Mariam Voutsis, MPA, Steven Humes, MM, MPH

Blood (2016) 128 (22): 1405.

https://doi.org/10.1182/blood.V128.22.1405.1405

Published: 2016

Journal Articles

Linear and Logistic Regression Models of Patient-Reported Outcomes and Patient Characteristics in US Adults with Hemophilia from the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study

Katharine Batt, MD MSc, Michael Recht, MD PhD, Michael Wang, MD, Doris V. Quon, MD PhD, Lisa N Boggio, MD MS, Craig M. Kessler, MD, Tyler W. Buckner, MD MSc, Anne T. Neff, MD, Neeraj N Iyer, PhD, David L Cooper, MD MBA, Christine L Kempton, MD MSc

Blood (2016) 128 (22): 252.

https://doi.org/10.1182/blood.V128.22.252.252

Published: 2016

Journal Articles

Characteristics of Patients without Bleeding in a Pivotal Trial of Extended Half-Life, Pegylated, Full-length Recombinant Factor VIII (BAX 855) in the Treatment of Hemophilia A

Alice D. Ma, MD, Robert Klamroth, Marilyn J. Manco-Johnson, MD, Werner Engl, Jacqueline A Dyck-Jones, PhD, Brigitt E. Abbuehl

Blood (2015) 126 (23): 1105.

https://doi.org/10.1182/blood.V126.23.1105.1105

Published: 2015

Journal Articles

Joint Bleeding Patterns in Patients Treated Prophylactically with an Extended Half-Life, Pegylated, Full-Length Recombinant Factor VIII (BAX 855)

Marilyn J. Manco-Johnson, MD, Alice D. Ma, MD, Robert Klamroth, Werner Engl, Lorena Griparic, PhD, Jacqueline A Dyck-Jones, PhD, Brigitt E. Abbuehl

Blood (2015) 126 (23): 2300.

https://doi.org/10.1182/blood.V126.23.2300.2300

Published: 2015

Journal Articles

Low Bone Density In Sickle Cell Disease Is a Risk Factor in The Development Of Avascular Necrosis

Hassan A. Al-Jafar, MBChB , MD, Leena M Aytoglu, BSC - MSC ( Master in molecular medecine ), Jehan Al-Shemmari, PhD, Uzma Afzal, Iman Al-Shemmari, Saud Al-Enizi

Blood (2013) 122 (21): 4688.

https://doi.org/10.1182/blood.V122.21.4688.4688

Published: 2013

Journal Articles

Postoperative Blood Use Following Elective Total Hip and Total Knee Arthroplasty

John Murnaghan, MD, MSc, MA, FRCSC, Yulia Lin, MD, Helen Razmjou, PhD, Jeffrey Gollish, MD, Deborah Murnaghan, RN

Blood (2012) 120 (21): 1181.

https://doi.org/10.1182/blood.V120.21.1181.1181

Published: 2012

Journal Articles

Patterns of Bleeding in Males with Von Willebrand Disease

Manpreet K. Sandhu, MD, Shailja Shah, Sari H Jacoby, Alice J. Cohen, MD

Blood (2012) 120 (21): 1129.

https://doi.org/10.1182/blood.V120.21.1129.1129

Published: 2012

Journal Articles

Pharmacokinetics of Continuous Infusion Therapy of Factor VIII Concentrates in Hemophilia A Patients with Inhibitors,

Katsumi Nishiya, MD, PhD, Ichiro Tanaka, MD, PhD, Keiji Nogami, MD, PhD, Kenichi Ogiwara, MD, PhD, Koji Yada, MD, Tomoko Matsumoto, Midori Shima, MD, PhD

Blood (2011) 118 (21): 3320.

https://doi.org/10.1182/blood.V118.21.3320.3320

Published: 2011

Journal Articles

Transfusion and Post-Hospital Discharge Outcomes In Elective Total Hip Replacement (THR) or Total Knee Replacement (TKR) Surgery Among Adults <65 Years of Age.

Lorie Ellis, PhD, Robert A. Bailey, MD, FASN, Jamie B. Forlenza, PharmD, MS, Mekré Senbetta, PharmD, Pamela Landsman-Blumberg, DrPH

Blood (2010) 116 (21): 3814.

https://doi.org/10.1182/blood.V116.21.3814.3814

Published: 2010

Journal Articles

Transfusion and Inpatient Outcomes In Elective Total Hip Replacement (THR) or Total Knee Replacement (TKR) Surgery Among Adults <65 Years of Age

Lorie Ellis, PhD, Robert A. Bailey, MD, FASN, Jamie B. Forlenza, PharmD, MS, Mekré Senbetta, PharmD, Pamela Landsman-Blumberg, DrPH

Blood (2010) 116 (21): 4761.

https://doi.org/10.1182/blood.V116.21.4761.4761

Published: 2010

Journal Articles

Similarity in Joint Function Limitation in Type 3 VWD and Moderate Hemophilia A

Suman Sood, MD, Adam Cuker, MD, Chengbin Wang, Ph.D., Ara Metjian, MD, Elaine Y Chiang, J. Michael Soucie, Ph.D., Barbara A. Konkle, MD, Htcn Investigators

Blood (2008) 112 (11): 426.

https://doi.org/10.1182/blood.V112.11.426.426

Published: 2008

Journal Articles

Patient-Related Outcomes of Elective Major Orthopedic Surgery in Severe Hemophilia Patients: A Review of the Literature and a Proposed Agenda for Research.

Marc F. Botteman, MSc, Rahul Ballal, Ashish V. Joshi, PhD

Blood (2007) 110 (11): 965.

https://doi.org/10.1182/blood.V110.11.965.965

Published: 2007

Journal Articles

Current Prevalence of Specific Clinical Outcomes in Adult Patients with Hb SS or Hb Sβ 0 Thalassemia.

Laura M. De Castro, MD, Felicia C. Lennon-Graham, MBA, Allison G. Ashley-Koch, PhD, Jude C. Jonassaint, RN, James J. Eckman, MD, Eugene P. Orringer, MD, Marilyn J. Telen, MD

Blood (2006) 108 (11): 1201.

https://doi.org/10.1182/blood.V108.11.1201.1201

Published: 2006

NARROW

Epidemiology of Inhibitors in Persons with Severe Hemophilia a in the United States: Analyses of a National Database

Early Prophylaxis Provides Continued Joint Protection in Severe Hemophilia A: Results of the Joint Outcome Continuation Study

Outcomes of Severe Hemophilia a Patients on Continuous Prophylaxis Relative to Inhibitor Status in the Community Counts Registry

Linear and Logistic Regression Models of Patient-Reported Outcomes and Patient Characteristics in US Adults with Hemophilia from the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study

Characteristics of Patients without Bleeding in a Pivotal Trial of Extended Half-Life, Pegylated, Full-length Recombinant Factor VIII (BAX 855) in the Treatment of Hemophilia A

Joint Bleeding Patterns in Patients Treated Prophylactically with an Extended Half-Life, Pegylated, Full-Length Recombinant Factor VIII (BAX 855)

Low Bone Density In Sickle Cell Disease Is a Risk Factor in The Development Of Avascular Necrosis

Postoperative Blood Use Following Elective Total Hip and Total Knee Arthroplasty

Patterns of Bleeding in Males with Von Willebrand Disease

Pharmacokinetics of Continuous Infusion Therapy of Factor VIII Concentrates in Hemophilia A Patients with Inhibitors,

Transfusion and Post-Hospital Discharge Outcomes In Elective Total Hip Replacement (THR) or Total Knee Replacement (TKR) Surgery Among Adults <65 Years of Age.

Transfusion and Inpatient Outcomes In Elective Total Hip Replacement (THR) or Total Knee Replacement (TKR) Surgery Among Adults <65 Years of Age

Similarity in Joint Function Limitation in Type 3 VWD and Moderate Hemophilia A

Patient-Related Outcomes of Elective Major Orthopedic Surgery in Severe Hemophilia Patients: A Review of the Literature and a Proposed Agenda for Research.

Current Prevalence of Specific Clinical Outcomes in Adult Patients with Hb SS or Hb Sβ 0 Thalassemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only